Zurcher Kantonalbank (Zurich Cantonalbank) Keros Therapeutics, Inc. Transaction History

Zurcher Kantonalbank (Zurich Cantonalbank)

$32.8 Billion
Q3 2024

A detailed history of Zurcher Kantonalbank (Zurich Cantonalbank) transactions in Keros Therapeutics, Inc. stock. As of the latest transaction made, Zurcher Kantonalbank (Zurich Cantonalbank) holds 5,371 shares of KROS stock, worth $290,087. This represents 0.0% of its overall portfolio holdings.

Number of Shares

5,371

Previous 5,371 -0.0%

Holding current value

$290,087

Previous $311,000 -0.0%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	BUY	$41.68 - $58.07 $83,109 - $115,791	1,994 Added 59.05%	5,371 $311,000
Q2 2024 Jul 29, 2024	SELL	$44.58 - $66.89 $44 - $66	-1 Reduced 0.03%	3,377 $154,000
Q1 2024 Apr 25, 2024	BUY	$41.26 - $70.48 $12,419 - $21,214	301 Added 9.78%	3,378 $223,000
Q4 2023 Jan 30, 2024	SELL	$27.12 - $41.05 $1,003 - $1,518	-37 Reduced 1.19%	3,077 $122,000
Q3 2023 Oct 25, 2023	SELL	$31.57 - $43.02 $3,346 - $4,560	-106 Reduced 3.29%	3,114 $99,000
Q2 2023 Aug 07, 2023	BUY	$37.26 - $51.01 $100,266 - $137,267	2,691 Added 508.7%	3,220 $129,000
Q1 2023 May 08, 2023	BUY	$41.44 - $59.32 $4,889 - $6,999	118 Added 28.71%	529 $22,000
Q4 2022 Feb 01, 2023	SELL	$39.45 - $51.77 $3,116 - $4,089	-79 Reduced 16.12%	411 $19,000
Q2 2022 Aug 09, 2022	SELL	$26.03 - $67.04 $1,041 - $2,681	-40 Reduced 7.55%	490 $14,000
Q1 2022 Apr 21, 2022	SELL	$42.12 - $59.36 $10,698 - $15,077	-254 Reduced 32.4%	530 $29,000
Q4 2021 Feb 01, 2022	SELL	$36.95 - $62.89 $1,551 - $2,641	-42 Reduced 5.08%	784 $46,000
Q3 2021 Nov 15, 2021	SELL	$29.27 - $43.71 $321 - $480	-11 Reduced 1.31%	826 $33,000
Q2 2021 Jul 30, 2021	BUY	$42.4 - $70.11 $1,144 - $1,892	27 Added 3.33%	837 $36,000
Q1 2021 May 03, 2021	BUY	$54.0 - $75.28 $43,740 - $60,976	810 New	810 $50,000

Others Institutions Holding KROS

# of Institutions

174

Shares Held

30.3M

Call Options Held

76.8K

Put Options Held

View Full List

About Keros Therapeutics, Inc.

Ticker KROS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,757,000
Market Cap $1.39B
Description
Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need. The company's lead protein therapeutic product candidate is KER-050, which is being developed ...

More about KROS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Zurcher Kantonalbank (Zurich Cantonalbank), based on Form 13F filings with the SEC.

News

Stay updated on Zurcher Kantonalbank (Zurich Cantonalbank) with notifications on news.

Account

Zurcher Kantonalbank (Zurich Cantonalbank) Keros Therapeutics, Inc. Transaction History